Does bronchoalveolar lavage lymphocytosis predict prognosis in fibrotic hypersensitivity pneumonitis, and is this relationship influenced by low-dose immunomodulatory therapy at the time of BAL?
- DOI
- 10.3389/fmed.2026.1877266
- Published
- 2026
- Container
- Frontiers in medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fmed.2026.1877266,
title = {Does bronchoalveolar lavage lymphocytosis predict prognosis in fibrotic hypersensitivity pneumonitis, and is this relationship influenced by low-dose immunomodulatory therapy at the time of BAL?},
author = {Kaenmuang P and Danzo F and Bax S and Hewitt RJ and Kokosi M and Kouranos V and Chua F and George PM and Jenkins G and Wells AU and Stock CJW and Sestini P and Renzoni EA},
year = {2026},
journal = {Frontiers in medicine},
doi = {10.3389/fmed.2026.1877266},
url = {https://doi.org/10.3389/fmed.2026.1877266}
}RIS
TY - JOUR TI - Does bronchoalveolar lavage lymphocytosis predict prognosis in fibrotic hypersensitivity pneumonitis, and is this relationship influenced by low-dose immunomodulatory therapy at the time of BAL? AU - Kaenmuang P AU - Danzo F AU - Bax S AU - Hewitt RJ AU - Kokosi M AU - Kouranos V AU - Chua F AU - George PM AU - Jenkins G AU - Wells AU AU - Stock CJW AU - Sestini P AU - Renzoni EA PY - 2026 JO - Frontiers in medicine DO - 10.3389/fmed.2026.1877266 UR - https://doi.org/10.3389/fmed.2026.1877266 ER -
APA
P, K., F, D., S, B., RJ, H., M, K., V, K., F, C., PM, G., G, J., AU, W., CJW, S., P, S., & EA, R. (2026). Does bronchoalveolar lavage lymphocytosis predict prognosis in fibrotic hypersensitivity pneumonitis, and is this relationship influenced by low-dose immunomodulatory therapy at the time of BAL?. Frontiers in medicine. https://doi.org/10.3389/fmed.2026.1877266
Source records
- pubmed · retrieved 2026-09-26T19:41:47.657Z
- europe-pmc · retrieved 2026-09-26T19:41:47.671Z
- doaj · retrieved 2026-09-26T19:41:47.659Z